HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: AJPH.2004.040774v1 96/5/791    most recent Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Grossman, D. Articles by Rivas, F. T. Search for Related Content PubMed PubMed Citation Articles by Grossman, D. Articles by Rivas, F. T. Related Collections Contraception Health Policy Access to Care Women's Health

Daniel Grossman, MD, Charlotte Ellertson, PhD, MPA, Katrina Abuabara, MA, Kelly Blanchard, MSc and Francisco T. Rivas, JD, LLM

Daniel Grossman is with Ibis Reproductive Health, San Francisco, Calif. At the time of the study, Charlotte Ellertson was with Ibis Reproductive Health, Cambridge, Mass. Katrina Abuabara and Kelly Blanchard are with Ibis Reproductive Health, Cambridge, Mass. Francisco Rivas is an attorney in private practice in Downingtown, Pa.

Correspondence: Requests for reprints should be sent to Daniel Grossman, MD, Ibis Reproductive Health, 2 Brattle Square, Cambridge, MA 02138 (e-mail: dgrossman{at}ibisreproductivehealth.org).

Many contraceptives are encumbered with potentially unnecessary restrictions on their use. Indeed, fear of side effects, fostered by alarmist labeling, is a leading reason that women do not use contraceptives.

In the United States, hormonal methods currently require a prescription, although research suggests that women can adequately screen themselves for contraindications, manage side effects, and determine an appropriate initiation date, leaving little need for routine direct physician involvement. Sizing, spermicidal use, and length-of-wear limits burden users of cervical barriers and may be unnecessary. Despite recent changes in the labeling of intrauterine devices, clinicians commonly restrict use of this method and in some countries may limit the types of providers authorized to insert them.

Although in some cases additional research is necessary, existing data indicate that evidence-based demedicalization of contraceptive provision could reduce costs and improve access.

This article has been cited by other articles:

				D. Grossman Should the contraceptive pill be available without prescription? Yes BMJ, December 23, 2008; 337(dec23_2): a3044 - a3044. [Full Text]